Serum ferritin level is higher in poorly controlled patients with Type 2 diabetes and people without diabetes, aged over 55 years

Diabetic Medicine

Volumn 31, Issue 4, 2014, Pages 419-424

  Batchuluun, B ^a   Matsumata, T ^b   Erdenebileg, N ^c   Tsagaantsooj, G ^c   Boldbaatar, K ^c   Khasag, A ^c  

^a KYUSHU UNIVERSITY   (Japan)

^b Saiseikai Yahata General Hospital   (Japan)

^c MONGOLIAN NATIONAL UNIVERSITY OF MEDICAL SCIENCES   (Mongolia)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; FERRITIN; GLUCOSE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE SEVERITY; FEMALE; FERRITIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; HYPERFERRITINEMIA; IRON STORAGE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONGOLIA; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADULT; AGED; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FERRITINS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; IRON OVERLOAD; MALE; MIDDLE AGED; MONGOLIA;

EID: 84896134557     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12343     Document Type: Article

References (30)

1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87: 4-14.
2. Thomas MC, MacIsaac RJ, Tsalamandris C, Jerums G. Elevated iron indices in patients with diabetes. Diabet Med 2004; 21: 798-802.
3. Jiang R, Manson JE, Meigs JB, Ma J, Rifai N, Hu FB. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. J Am Med Assoc 2004; 291: 711-717.
4. Salonen JT, Tuomainen T-P, Nyyssonen K, Lakka H-M, Punnonen K. Relation between iron stores and non-insulin-dependent diabetes in men: case-control study. Br Med J 1998; 317: 727-730.
5. Fernandez-Real JM, Lopez-Bermejo A, Ricart W. Cross-talk between iron metabolism and diabetes. Diabetes 2002; 51: 2348-2354.
6. Tuomainen TP, Nyyssonen K, Salonen R, Tervahauta A, Korpela H, Lakka T et al. Body iron stores are associated with serum insulin and blood glucose concentrations: population study in 1013 eastern Finnish men. Diabetes Care 1997; 20: 426-428.
7. Jehn M, Clark JM, Guallar E. Serum ferritin and risk of the metabolic syndrome in US adults. Diabetes Care 2004; 27: 2422-2428.
8. Bozzini C, Girelli D, Olivieri O, Martinelli N, Bassi A, De Matteis G et al. Prevalence of body iron excess in the metabolic syndrome. Diabetes Care 2005; 28: 2061-2063.
9. Waalen J, Felitti VJ, Gelbart T, Beutler E. Screening for hemochromatosis by measuring ferritin levels: a more effective approach. Blood 2008; 111: 3373-3376.
10. Dmochowski K, Finegood DT, Fran Combe W, Tyler BZB. Factors determining glucose tolerance in patients with thalassemia major. J Clin Endocrinal Metab 1993; 77: 478-483.
11. Cavallo-Perin P, Pacini G, Cerutti F, Bessone A, Condo C, Sacchetti L et al. Insulin resistance and hyperinsulinemia in homozygous β-thalassemia. Metabolism 1995; 44: 281-286.
12. Ferrannini E. Insulin resistance, iron and the liver. Lancet 2000; 355: 2181-2182.
13. Niederau C, Berger M, Stremmel W, Starke A, Strohmeyer G, Ebert R et al. Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation? Diabetologia 1984; 26: 441-444.
14. Ford ES, Cogswell ME. Diabetes and serum ferritin concentration among US adults. Diabetes Care 1999; 22: 1978-1983.
15. Canturk Z, Cetinarslan B, Tarkun I, Canturk NZ. Serum ferritin levels in poorly and well-controlled diabetes mellitus. Endocr Res 2003; 29: 299-306.
16. O'Brien T, Barrett B, Murray DM, Dinneen S, O'Sullivan DJ. Usefulness of biochemical screening of diabetic patients for hemochromatosis. Diabetes Care 1990; 13: 532-534.
17. Kaye TB, Guay AT, Simonson DC. Non-insulin-dependent diabetes mellitus and elevated serum ferritin level. J Diabetes Complications 1993; 7: 246-249.
18. Fernandez-Real JM, Bermejo AL, Ricart W. Crosstalk between iron metabolism and diabetes. J Diabetes 2002; 51: 2348-2354.
19. Redmon JB, Pyzdrowski KL, Robertson RP. No effect of deferoxamine therapy on glucose homeostasis and insulin secretion in individuals with NIDDM and elevated serum ferritin. Diabetes 1993; 42: 544-549.
20. Sharifi F, Nasab NM, Zadeh HJ. Elevated serum ferritin concentrations in pre-diabetic subjects. Diab Vasc Dis Res 2008; 5: 15-18.
21. Ascherio A, Millett WC, Rimm EB. Giovannucci El Stampfer MJ. Blood donation and risk of coronary heart disease in men. Circulation 2001; 103: 52-57.
22. Van Oost BA, Van den Beld B, Cloin LGLM, Marx JJM. Measurement of ferritin in serum: application in diagnostic use. Clin Biochem 1984; 17: 263-269.
23. 1c. Acta Medica Iranica 2004; 42: 142-145.
24. Forouhi NG, Harding AH, Allison M, Sandhu MS, Welch A, Luben R et al. Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study. Diabetologia 2007; 50: 949-956.
25. Wolff SP. Diabetes mellitus and free radicals: free radicals, transition metals and oxidative stress in the aetiology of diabetes mellitus and complications. Br Med Bull 1993; 49: 642-652.
26. Shi Z, Hu X. Association between serum ferritin, hemoglobin, iron intake and diabetes in adults in Jiangsu. China. Diabetes Care 2006; 29: 1878-1883.
27. Luan DC, Li H, Li SJ. Body iron stores and dietary iron intake in relation to diabetes in adults in North China. Diabetes Care 2008; 31: 285-286.
28. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003; 107: 363-369.
29. Hahn P, Ying GS, Beard J, Dunaief JL. Iron levels in human retina: sex difference and increase with age. Neuroreport 2006; 17: 1803-1806.
30. Jiang R, Ma J, Ascherio A, Stampfer MJ, Willett WC, Hu FB. Dietary iron intake and blood donations in relation to risk of type 2 diabetes in men: a prospective cohort study. Am J Clin Nutr 2004; 79: 70-75.